What sets The Moran Company apart from other firms that provide general reimbursement consulting is our expert understanding of the reimbursement challenges in both the private and public sectors. Not only do we understand the historical and current policy environment, we are recognized experts in the diverse and complex reimbursement systems used by Medicare, Medicaid, and the private sector in assessing the value of, and reimbursement for, technology and its related services. Moreover, unlike other firms, we have developed highly technical analytic capabilities to support sound policy analysis.

The services that TMC can provide our clients draw on our expertise using Medicare (and some national) data to support the analytics necessary to provide sound strategic policy advice. Moreover, TMC is a recognized expert in modeling complex Medicare reimbursement systems and can provide unique, targeted reimbursement analysis.


Hospital Charges and Reimbursement for Medicines: 2023 Update Analysis of Markups Relative to Acquisition Cost – August 2023

PhRMA MFN Analysis & CMS Impact Critique – January 2021

CAR T Hospital & Patient Issue Brief – December 2020

Hospital Charges & Reimbursements for Drugs – July 2019

PhRMA Part B Drugs 2012 and 2017

Hospital Charges and Reimbursement for Drugs – October 2017

Summary MEPS Analysis